SCHEDULE 13G/A
Statement of Beneficial Ownership
CRISPR Therapeutics AG Filed Acc 0001104659-26-126825
Stakes reported in this filing
| Reporting person | Shares | Of the class |
|---|---|---|
| ARK Investment Management LLC | 10,056,844 | 10.40% |
| Catherine D. Wood | 10,056,844 | 10.40% |
Members of a group can each report the same shares, so these rows overlap and don't add up.
Stake history · largest stake in each 13D and 13G
Loading xslSCHEDULE_13G_X02/primary_doc.xml…